‘Water pill’ best start for curbing blood pressure
|
Tweet
|
|
There are several classes of drugs for lowering High Blood Pressure, but the best type to begin with is one of the oldest and cheapest: a ‘water pill’ or diuretic, researchers say.
Results of a big study called ALLHAT (standing for Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) show that the diuretic chlorthalidone is as good as an ACE inhibitor (lisinopril) or a calcium channel blocker (amlodipine) in preventing major heart or kidney complications resulting from High Blood Pressure. Chlorthalidone actually comes out ahead in its ability to prevent heart failure.
Based on the findings, Dr. Jackson T. Wright, at Case Western Reserve University in Cleveland, and his associates advise that diuretics should be considered the drug of choice for initial therapy of hypertension for both blacks and non-blacks.
As reported in this week’s Journal of the American Medical Association, ALLHAT included 33,357 patients with High Blood Pressure, 35 percent of whom were black; they were 55 years of age or older with at least one other risk factor for Heart disease.
The subjects were randomly assigned to treatment with chlorthalidone, amlodipine or lisinopril. Other drugs were added as need to attain a blood pressure of 140-over-90 or lower.
After an average follow-up of nearly five years, Wright’s group found no significant differences among the treatment groups in the rates of heart attack or fatal coronary heart disease among blacks or non-blacks.
However, for those on the calcium blocker, the risk of heart failure was 46 percent higher in blacks and 32 percent higher in non-blacks than among those treated with the diuretic.
For those treated with the ACE inhibitor, compared with the diuretic, the risk of Stroke was 40% higher for blacks but not non-blacks. The risk of heart failure was raised for both subgroups.
The authors of the analysis point out that “ALLHAT is the first large-scale trial with a substantial number of black participants” aimed at evaluating different blood pressure treatments.
SOURCE: Journal of the American Medical Association, April 6, 2005.
Revision date: July 9, 2011
Last revised: by Tatiana Kuznetsova, D.M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

